Loading…
Percutaneous Renal Tumor Ablation: Radiation Exposure During Cryoablation and Radiofrequency Ablation
Introduction Once reserved solely for non-surgical cases, percutaneous ablation is becoming an increasingly popular treatment option for a wider array of patients with small renal masses and the radiation risk needs to be better defined as this transition continues. Materials and Methods Retrospecti...
Saved in:
| Published in: | Cardiovascular and interventional radiology 2016-02, Vol.39 (2), p.233-238 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c400t-2debddb77f1d45c6e9197d0147b18605b2025b774411676a534c43cc62f384b53 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c400t-2debddb77f1d45c6e9197d0147b18605b2025b774411676a534c43cc62f384b53 |
| container_end_page | 238 |
| container_issue | 2 |
| container_start_page | 233 |
| container_title | Cardiovascular and interventional radiology |
| container_volume | 39 |
| creator | McEachen, James C. Leng, Shuai Atwell, Thomas D. Tollefson, Matthew K. Friese, Jeremy L. Wang, Zhen Murad, M. Hassan Schmit, Grant D. |
| description | Introduction
Once reserved solely for non-surgical cases, percutaneous ablation is becoming an increasingly popular treatment option for a wider array of patients with small renal masses and the radiation risk needs to be better defined as this transition continues.
Materials and Methods
Retrospective review of our renal tumor ablation database revealed 425 patients who underwent percutaneous ablation for treatment of 455 renal tumors over a 5-year time period. Imparted radiation dose information was reviewed for each procedure and converted to effective patient dose and skin dose using established techniques. Statistical analysis was performed with each ablative technique.
Results
For the 331 cryoablation procedures, the mean DLP was 6987 mGycm (SD = 2861) resulting in a mean effective dose of 104.7 mSv (SD = 43.5) and the mean CTDI
vol
was 558 mGy (SD = 439) resulting in a mean skin dose of 563.2 mGy (SD = 344.1). For the 124 RFA procedures, the mean DLP was 3485 mGycm (SD = 1630) resulting in a mean effective dose of 50.3 mSv (SD = 24.0) and the mean CTDI
vol
was 232 mGy (SD = 149) resulting in a mean skin dose of 233.2 mGy (SD = 117.4). The difference in patient radiation exposure between the two renal ablation techniques was statistically significant (
p
|
| doi_str_mv | 10.1007/s00270-015-1169-1 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_22469603</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1762344838</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-2debddb77f1d45c6e9197d0147b18605b2025b774411676a534c43cc62f384b53</originalsourceid><addsrcrecordid>eNp1kU9P2zAYh61paHSFD8BlirQLl4z39d-EGyqwTUICoSJxsxzH2YLSuNiJtH573KZ0u-xkS37en-3fQ8gZwjcEUBcRgCrIAUWOKMscP5AZckZzKOTzRzIDVDxHIfCYfI7xBRJYUPGJHFOJomRCzIh7cMGOg-mdH2P26HrTZctx5UN2VXVmaH1_mT2aut1ts5s_ax_H4LLrMbT9r2wRNt7sucz09Q71TXCvo-vt5pBxQo4a00V3ul_n5On2Zrn4kd_df_-5uLrLLQcYclq7qq4rpRqsubDSlViqGpCrCgsJoqJARTrmPH1XSSMYt5xZK2nDCl4JNidfp1wfh1ZH2w7O_ra-750dNKVclhJYos4nah18emgc9KqN1nXd1IJGJSnjvGDF38AD-uLHkEraUZhqZJwmCifKBh9jcI1eh3ZlwkYj6K0pPZnSSYDemtKYZr7sk8dq5erDxLuaBNAJiOtt1y78c_V_U98ABRKczg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1761615342</pqid></control><display><type>article</type><title>Percutaneous Renal Tumor Ablation: Radiation Exposure During Cryoablation and Radiofrequency Ablation</title><source>Springer Link</source><creator>McEachen, James C. ; Leng, Shuai ; Atwell, Thomas D. ; Tollefson, Matthew K. ; Friese, Jeremy L. ; Wang, Zhen ; Murad, M. Hassan ; Schmit, Grant D.</creator><creatorcontrib>McEachen, James C. ; Leng, Shuai ; Atwell, Thomas D. ; Tollefson, Matthew K. ; Friese, Jeremy L. ; Wang, Zhen ; Murad, M. Hassan ; Schmit, Grant D.</creatorcontrib><description>Introduction
Once reserved solely for non-surgical cases, percutaneous ablation is becoming an increasingly popular treatment option for a wider array of patients with small renal masses and the radiation risk needs to be better defined as this transition continues.
Materials and Methods
Retrospective review of our renal tumor ablation database revealed 425 patients who underwent percutaneous ablation for treatment of 455 renal tumors over a 5-year time period. Imparted radiation dose information was reviewed for each procedure and converted to effective patient dose and skin dose using established techniques. Statistical analysis was performed with each ablative technique.
Results
For the 331 cryoablation procedures, the mean DLP was 6987 mGycm (SD = 2861) resulting in a mean effective dose of 104.7 mSv (SD = 43.5) and the mean CTDI
vol
was 558 mGy (SD = 439) resulting in a mean skin dose of 563.2 mGy (SD = 344.1). For the 124 RFA procedures, the mean DLP was 3485 mGycm (SD = 1630) resulting in a mean effective dose of 50.3 mSv (SD = 24.0) and the mean CTDI
vol
was 232 mGy (SD = 149) resulting in a mean skin dose of 233.2 mGy (SD = 117.4). The difference in patient radiation exposure between the two renal ablation techniques was statistically significant (
p
< 0.001).
Conclusion
Both cryoablation and RFA imparted an average skin dose that was well below the 2 Gy deterministic threshold for appreciable sequela. Renal tumor cryoablation resulted in a mean skin and effective radiation dose more than twice that for RFA. The radiation exposure for both renal tumor ablation techniques was at the high end of the medical imaging radiation dose spectrum.</description><identifier>ISSN: 0174-1551</identifier><identifier>EISSN: 1432-086X</identifier><identifier>DOI: 10.1007/s00270-015-1169-1</identifier><identifier>PMID: 26159355</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>ABLATION ; Aged ; BIOMEDICAL RADIOGRAPHY ; Cardiology ; Catheter Ablation - methods ; Clinical Investigation ; Cryosurgery - methods ; Female ; Humans ; Imaging ; Kidney Neoplasms - surgery ; KIDNEYS ; Male ; Medicine ; Medicine & Public Health ; NEOPLASMS ; Nuclear Medicine ; PATIENTS ; RADIATION DOSES ; Radiation Exposure ; Radio Waves ; Radiology ; RADIOLOGY AND NUCLEAR MEDICINE ; RADIOWAVE RADIATION ; Retrospective Studies ; REVIEWS ; Risk Factors ; SKIN ; SURGERY ; Treatment Outcome ; Ultrasound</subject><ispartof>Cardiovascular and interventional radiology, 2016-02, Vol.39 (2), p.233-238</ispartof><rights>Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2015</rights><rights>Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-2debddb77f1d45c6e9197d0147b18605b2025b774411676a534c43cc62f384b53</citedby><cites>FETCH-LOGICAL-c400t-2debddb77f1d45c6e9197d0147b18605b2025b774411676a534c43cc62f384b53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26159355$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/22469603$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>McEachen, James C.</creatorcontrib><creatorcontrib>Leng, Shuai</creatorcontrib><creatorcontrib>Atwell, Thomas D.</creatorcontrib><creatorcontrib>Tollefson, Matthew K.</creatorcontrib><creatorcontrib>Friese, Jeremy L.</creatorcontrib><creatorcontrib>Wang, Zhen</creatorcontrib><creatorcontrib>Murad, M. Hassan</creatorcontrib><creatorcontrib>Schmit, Grant D.</creatorcontrib><title>Percutaneous Renal Tumor Ablation: Radiation Exposure During Cryoablation and Radiofrequency Ablation</title><title>Cardiovascular and interventional radiology</title><addtitle>Cardiovasc Intervent Radiol</addtitle><addtitle>Cardiovasc Intervent Radiol</addtitle><description>Introduction
Once reserved solely for non-surgical cases, percutaneous ablation is becoming an increasingly popular treatment option for a wider array of patients with small renal masses and the radiation risk needs to be better defined as this transition continues.
Materials and Methods
Retrospective review of our renal tumor ablation database revealed 425 patients who underwent percutaneous ablation for treatment of 455 renal tumors over a 5-year time period. Imparted radiation dose information was reviewed for each procedure and converted to effective patient dose and skin dose using established techniques. Statistical analysis was performed with each ablative technique.
Results
For the 331 cryoablation procedures, the mean DLP was 6987 mGycm (SD = 2861) resulting in a mean effective dose of 104.7 mSv (SD = 43.5) and the mean CTDI
vol
was 558 mGy (SD = 439) resulting in a mean skin dose of 563.2 mGy (SD = 344.1). For the 124 RFA procedures, the mean DLP was 3485 mGycm (SD = 1630) resulting in a mean effective dose of 50.3 mSv (SD = 24.0) and the mean CTDI
vol
was 232 mGy (SD = 149) resulting in a mean skin dose of 233.2 mGy (SD = 117.4). The difference in patient radiation exposure between the two renal ablation techniques was statistically significant (
p
< 0.001).
Conclusion
Both cryoablation and RFA imparted an average skin dose that was well below the 2 Gy deterministic threshold for appreciable sequela. Renal tumor cryoablation resulted in a mean skin and effective radiation dose more than twice that for RFA. The radiation exposure for both renal tumor ablation techniques was at the high end of the medical imaging radiation dose spectrum.</description><subject>ABLATION</subject><subject>Aged</subject><subject>BIOMEDICAL RADIOGRAPHY</subject><subject>Cardiology</subject><subject>Catheter Ablation - methods</subject><subject>Clinical Investigation</subject><subject>Cryosurgery - methods</subject><subject>Female</subject><subject>Humans</subject><subject>Imaging</subject><subject>Kidney Neoplasms - surgery</subject><subject>KIDNEYS</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>NEOPLASMS</subject><subject>Nuclear Medicine</subject><subject>PATIENTS</subject><subject>RADIATION DOSES</subject><subject>Radiation Exposure</subject><subject>Radio Waves</subject><subject>Radiology</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>RADIOWAVE RADIATION</subject><subject>Retrospective Studies</subject><subject>REVIEWS</subject><subject>Risk Factors</subject><subject>SKIN</subject><subject>SURGERY</subject><subject>Treatment Outcome</subject><subject>Ultrasound</subject><issn>0174-1551</issn><issn>1432-086X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kU9P2zAYh61paHSFD8BlirQLl4z39d-EGyqwTUICoSJxsxzH2YLSuNiJtH573KZ0u-xkS37en-3fQ8gZwjcEUBcRgCrIAUWOKMscP5AZckZzKOTzRzIDVDxHIfCYfI7xBRJYUPGJHFOJomRCzIh7cMGOg-mdH2P26HrTZctx5UN2VXVmaH1_mT2aut1ts5s_ax_H4LLrMbT9r2wRNt7sucz09Q71TXCvo-vt5pBxQo4a00V3ul_n5On2Zrn4kd_df_-5uLrLLQcYclq7qq4rpRqsubDSlViqGpCrCgsJoqJARTrmPH1XSSMYt5xZK2nDCl4JNidfp1wfh1ZH2w7O_ra-750dNKVclhJYos4nah18emgc9KqN1nXd1IJGJSnjvGDF38AD-uLHkEraUZhqZJwmCifKBh9jcI1eh3ZlwkYj6K0pPZnSSYDemtKYZr7sk8dq5erDxLuaBNAJiOtt1y78c_V_U98ABRKczg</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>McEachen, James C.</creator><creator>Leng, Shuai</creator><creator>Atwell, Thomas D.</creator><creator>Tollefson, Matthew K.</creator><creator>Friese, Jeremy L.</creator><creator>Wang, Zhen</creator><creator>Murad, M. Hassan</creator><creator>Schmit, Grant D.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>OTOTI</scope></search><sort><creationdate>20160201</creationdate><title>Percutaneous Renal Tumor Ablation: Radiation Exposure During Cryoablation and Radiofrequency Ablation</title><author>McEachen, James C. ; Leng, Shuai ; Atwell, Thomas D. ; Tollefson, Matthew K. ; Friese, Jeremy L. ; Wang, Zhen ; Murad, M. Hassan ; Schmit, Grant D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-2debddb77f1d45c6e9197d0147b18605b2025b774411676a534c43cc62f384b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>ABLATION</topic><topic>Aged</topic><topic>BIOMEDICAL RADIOGRAPHY</topic><topic>Cardiology</topic><topic>Catheter Ablation - methods</topic><topic>Clinical Investigation</topic><topic>Cryosurgery - methods</topic><topic>Female</topic><topic>Humans</topic><topic>Imaging</topic><topic>Kidney Neoplasms - surgery</topic><topic>KIDNEYS</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>NEOPLASMS</topic><topic>Nuclear Medicine</topic><topic>PATIENTS</topic><topic>RADIATION DOSES</topic><topic>Radiation Exposure</topic><topic>Radio Waves</topic><topic>Radiology</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>RADIOWAVE RADIATION</topic><topic>Retrospective Studies</topic><topic>REVIEWS</topic><topic>Risk Factors</topic><topic>SKIN</topic><topic>SURGERY</topic><topic>Treatment Outcome</topic><topic>Ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McEachen, James C.</creatorcontrib><creatorcontrib>Leng, Shuai</creatorcontrib><creatorcontrib>Atwell, Thomas D.</creatorcontrib><creatorcontrib>Tollefson, Matthew K.</creatorcontrib><creatorcontrib>Friese, Jeremy L.</creatorcontrib><creatorcontrib>Wang, Zhen</creatorcontrib><creatorcontrib>Murad, M. Hassan</creatorcontrib><creatorcontrib>Schmit, Grant D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>Cardiovascular and interventional radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McEachen, James C.</au><au>Leng, Shuai</au><au>Atwell, Thomas D.</au><au>Tollefson, Matthew K.</au><au>Friese, Jeremy L.</au><au>Wang, Zhen</au><au>Murad, M. Hassan</au><au>Schmit, Grant D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Percutaneous Renal Tumor Ablation: Radiation Exposure During Cryoablation and Radiofrequency Ablation</atitle><jtitle>Cardiovascular and interventional radiology</jtitle><stitle>Cardiovasc Intervent Radiol</stitle><addtitle>Cardiovasc Intervent Radiol</addtitle><date>2016-02-01</date><risdate>2016</risdate><volume>39</volume><issue>2</issue><spage>233</spage><epage>238</epage><pages>233-238</pages><issn>0174-1551</issn><eissn>1432-086X</eissn><abstract>Introduction
Once reserved solely for non-surgical cases, percutaneous ablation is becoming an increasingly popular treatment option for a wider array of patients with small renal masses and the radiation risk needs to be better defined as this transition continues.
Materials and Methods
Retrospective review of our renal tumor ablation database revealed 425 patients who underwent percutaneous ablation for treatment of 455 renal tumors over a 5-year time period. Imparted radiation dose information was reviewed for each procedure and converted to effective patient dose and skin dose using established techniques. Statistical analysis was performed with each ablative technique.
Results
For the 331 cryoablation procedures, the mean DLP was 6987 mGycm (SD = 2861) resulting in a mean effective dose of 104.7 mSv (SD = 43.5) and the mean CTDI
vol
was 558 mGy (SD = 439) resulting in a mean skin dose of 563.2 mGy (SD = 344.1). For the 124 RFA procedures, the mean DLP was 3485 mGycm (SD = 1630) resulting in a mean effective dose of 50.3 mSv (SD = 24.0) and the mean CTDI
vol
was 232 mGy (SD = 149) resulting in a mean skin dose of 233.2 mGy (SD = 117.4). The difference in patient radiation exposure between the two renal ablation techniques was statistically significant (
p
< 0.001).
Conclusion
Both cryoablation and RFA imparted an average skin dose that was well below the 2 Gy deterministic threshold for appreciable sequela. Renal tumor cryoablation resulted in a mean skin and effective radiation dose more than twice that for RFA. The radiation exposure for both renal tumor ablation techniques was at the high end of the medical imaging radiation dose spectrum.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>26159355</pmid><doi>10.1007/s00270-015-1169-1</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0174-1551 |
| ispartof | Cardiovascular and interventional radiology, 2016-02, Vol.39 (2), p.233-238 |
| issn | 0174-1551 1432-086X |
| language | eng |
| recordid | cdi_osti_scitechconnect_22469603 |
| source | Springer Link |
| subjects | ABLATION Aged BIOMEDICAL RADIOGRAPHY Cardiology Catheter Ablation - methods Clinical Investigation Cryosurgery - methods Female Humans Imaging Kidney Neoplasms - surgery KIDNEYS Male Medicine Medicine & Public Health NEOPLASMS Nuclear Medicine PATIENTS RADIATION DOSES Radiation Exposure Radio Waves Radiology RADIOLOGY AND NUCLEAR MEDICINE RADIOWAVE RADIATION Retrospective Studies REVIEWS Risk Factors SKIN SURGERY Treatment Outcome Ultrasound |
| title | Percutaneous Renal Tumor Ablation: Radiation Exposure During Cryoablation and Radiofrequency Ablation |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T13%3A35%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Percutaneous%20Renal%20Tumor%20Ablation:%20Radiation%20Exposure%20During%20Cryoablation%20and%20Radiofrequency%20Ablation&rft.jtitle=Cardiovascular%20and%20interventional%20radiology&rft.au=McEachen,%20James%20C.&rft.date=2016-02-01&rft.volume=39&rft.issue=2&rft.spage=233&rft.epage=238&rft.pages=233-238&rft.issn=0174-1551&rft.eissn=1432-086X&rft_id=info:doi/10.1007/s00270-015-1169-1&rft_dat=%3Cproquest_osti_%3E1762344838%3C/proquest_osti_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c400t-2debddb77f1d45c6e9197d0147b18605b2025b774411676a534c43cc62f384b53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1761615342&rft_id=info:pmid/26159355&rfr_iscdi=true |